Punch & Associates Investment Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,884,154
Closed -$35.6M 177
2024
Q4
$35.6M Sell
2,884,154
-49,379
-2% -$566K 1.94% 6
2024
Q3
$33.4M Buy
2,933,533
+16,493
+0.6% +$166K 1.84% 7
2024
Q2
$20.8M Buy
2,917,040
+984,650
+51% +$7.53M 1.22% 18
2024
Q1
$12.9M Buy
1,932,390
+599,399
+45% +$4.12M 0.74% 44
2023
Q4
$8.66M Buy
1,332,991
+146,352
+12% +$943K 0.51% 83
2023
Q3
$11.2M Buy
1,186,639
+155,817
+15% +$1.88M 0.72% 45
2023
Q2
$14.4M Buy
1,030,822
+211,681
+26% +$3.61M 0.88% 31
2023
Q1
$15.4M Buy
819,141
+9,250
+1% +$152K 0.99% 23
2022
Q4
$11.2M Sell
809,891
-16,456
-2% -$252K 0.72% 50
2022
Q3
$15.8M Buy
826,347
+194,335
+31% +$3.54M 1.1% 20
2022
Q2
$9.64M Sell
632,012
-5,128
-0.8% -$75.8K 0.67% 46
2022
Q1
$13M Buy
637,140
+19,206
+3% +$391K 0.74% 33
2021
Q4
$18M Sell
617,934
-112,816
-15% -$3.23M 0.94% 20
2021
Q3
$15.8M Sell
730,750
-34,030
-4% -$821K 0.9% 24
2021
Q2
$19.6M Buy
764,780
+7,145
+0.9% +$153K 1.11% 16
2021
Q1
$13.8M Buy
757,635
+9,185
+1% +$153K 0.83% 29
2020
Q4
$8.64M Buy
748,450
+367,815
+97% +$3.36M 0.6% 64
2020
Q3
$2.9M Buy
+380,635
New +$2.88M 0.25% 138

Other funds holding CDMO

Punch & Associates Investment Management's CDMO Position: Q1 2025 in Review

Punch & Associates Investment Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 2,884,154 shares — an estimated $35.6M sold.

Punch & Associates Investment Management first reported a position in CDMO in Q3 2020 and held it in 18 quarters. The position peaked at $35.6M in Q4 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Punch & Associates Investment Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Punch & Associates Investment Management sold 2,884,154 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $35.6M.
  • Punch & Associates Investment Management first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2020 and held it in 18 quarters.
  • Punch & Associates Investment Management's Avid Bioservices, Inc. Common Stock position peaked at $35.6M in Q4 2024.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Punch & Associates Investment Management's 13F filing for Q1 2025, filed 15 May 2025.